CollPlant Biotechnologies Ltd Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
CollPlant Biotechnologies Ltd (CLGN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $101.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-26
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|
| 2025-12-31 | $101.00K 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $58.00K 6-K · filed 2025-08-20 | ||
| 2024-12-31 | $572.00K 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $623.00K 6-K · filed 2025-08-20 | ||
| 2023-12-31 | $886.00K 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $870.00K 6-K · filed 2024-08-20 | ||
| 2022-12-31 | $219.00K 20-F · filed 2025-03-26 | ||
| 2022-06-30 | $220.00K 6-K · filed 2022-08-25 | ||
| 2021-12-31 | $557.00K 20-F · filed 2024-04-04 | ||
| 2021-06-30 | $188.00K 6-K · filed 2022-08-25 | $184.00K 6-K · filed 2021-08-19 | |
| 2020-12-31 | $23.00K 20-F · filed 2023-03-29 | ||
| 2020-06-30 | $23.00K 6-K · filed 2021-08-19 | ||
| 2019-12-31 | $97.00K 20-F · filed 2022-03-24 |